Altimetrik launches healthcare and life sciences AI center in Hyderabad

Altimetrik opened a Healthcare & Life Sciences Center of Excellence in Hyderabad, India, and launched PharmaOS, a life sciences agentic AI framework built to move clients from concept to validation in one week. The move is designed to help regulated healthcare and pharma teams deploy governed AI across high-stakes workflows without re-engineering for every model change.

Why it matters: - Altimetrik is targeting a fast-growing but highly regulated market where AI tools must meet compliance, traceability, and patient-safety requirements. - The new Center of Excellence is meant to help healthcare and life sciences clients build governed AI agents that can be used in real enterprise workflows. - PharmaOS is positioned to shorten the path from an idea to a validated AI use case, which could speed adoption in pharma and healthcare operations.

What happened: - Altimetrik opened a Healthcare & Life Sciences Center of Excellence in Hyderabad, India. - The company introduced PharmaOS as the center’s first offering. - PharmaOS is an agentic AI framework for life sciences built on Altimetrik’s ALTi AIOS™ operating system. - Altimetrik says PharmaOS can take a client from a defined use case to a validated, governed AI agent in one week. - The center is designed to support clients across drug discovery, clinical development, commercial operations, manufacturing, patient engagement, and care delivery.

The details: - The CoE brings together AI engineers and life sciences specialists. - The team is building AI agents that meet regulatory requirements and trace outputs to trusted sources. - PharmaOS includes more than 35 pre-built agents. - The agents cover commercial operations, clinical and regulatory review, manufacturing, responsible AI, and data modernisation. - The framework connects agents to enterprise processes and trusted data. - Supported workflows include healthcare provider engagement planning, clinical study report review, batch-release readiness, and GxP compliance checks. - ALTi AIOS separates the operating layer from the underlying model. - That setup allows clients to use Google Cloud, Gemini Enterprise, and OpenAI ChatGPT Enterprise and switch models without re-engineering agents. - Given a defined business challenge, agreed data access, and a bounded workflow, Altimetrik says its engineers and life sciences specialists can turn the agents into a working workflow on the client’s own data, tied to a measurable business KPI. - Clients can evaluate the workflow in their enterprise environment and decide on the next stage of investment. - The CoE is located in Altimetrik’s 22,000-square-foot office at Phoenix Equinox in Gachibowli, near HITEC City. - More than 300 Altimetrik employees work in that location. - The Hyderabad launch follows Altimetrik’s recent expansion in Pune and comes after the company said its global workforce passed 10,000.

Between the lines: - Altimetrik is leaning on Hyderabad’s pharma ecosystem to place the CoE near the companies and contract research organisations that are likely to shape its offerings. - The company is also drawing on the city’s pool of clinical, regulatory, quality, and engineering specialists. - The model reflects a broader industry push to make AI more usable in regulated settings by keeping humans in the loop and tying outputs to evidence. - PharmaOS appears designed as both a product and a co-innovation platform, with offerings expected to be built alongside clients across the industry.

What’s next: - Clients can start with a scoped, one-week co-innovation sprint on a specific problem. - Clients can also begin with a single high-value PharmaOS agent on an existing workflow. - Altimetrik is offering live demonstrations of PharmaOS on the client’s preferred enterprise AI platform. - The company expects to expand the portfolio beyond PharmaOS through client co-creation.

The bottom line: - Altimetrik is packaging regulated AI delivery, enterprise flexibility, and rapid validation into one healthcare and life sciences offering to speed adoption in a cautious industry.